{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigpjnckiicfv6b6ksdwlt3vtjogapsxvxkcffoptytejuj47vldw4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mi3qsqqblxt2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihxoumxbgzhhmtf3ilmkcs2advq2ztn7b2gobgxkexnyoft76jynm"
    },
    "mimeType": "image/jpeg",
    "size": 64564
  },
  "path": "/2026/03/27/most-favored-nation-drug-prices-white-house-negotiations-pharma/?utm_campaign=rss",
  "publishedAt": "2026-03-27T17:21:48.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Exclusive",
    "Insurance",
    "Pharma",
    "Politics",
    "Prescription Politics",
    "biotechnology",
    "Congress",
    "Donald Trump",
    "Drug prices",
    "Pharmaceuticals",
    "Policy",
    "STAT+",
    "White House"
  ],
  "textContent": "The White House is working to build support for drug pricing legislation, part of an election year focus on affordability.",
  "title": "STAT+: In private meetings, White House works to win pharma companies’ support for drug pricing bill",
  "updatedAt": "2026-03-27T17:29:53.000Z"
}